ABSTRACT
The regulation and control of drugs and doping practices is the most high profile and highly sensitive issue facing international sport at the present time. Recent developments include disputes regarding a spate of nandrolonerelated ‘offences’ committed by athletes as well as controversy surrounding the introduction of blood and urine testing for the substance known as EPO (erythropoietin), which commenced at the Sydney Summer Olympic Games in 2000.
